angioblast


Also found in: Medical, Wikipedia.

angioblast

[′an·jē·ə‚blast]
(embryology)
A mesenchyme cell derived from extraembryonic endoderm that differentiates into embryonic blood cells and endothelium.
References in periodicals archive ?
Aastrom Biosciences Advanced BioHealing Advanced Cell Technology Advanced Tissue Sciences Advantagene AlloSource AlphaTec Spine Amedica Amgen Amorcyte Amorepacific Group AnGes MG Angioblast Systems Anika Therapeutics Anterogen Arcarios B.
Acquired 100% of Angioblast and entire intellectual property for MPCs
Articles then review strategies for cell delivery, clinical trials, therapies such as whole bone marrow transplantation, clinical angioblast therapy and the use of skeletal myoblasts and other techniques, and the future of the field.
Angioblast and Mesoblast are conducting a Pilot Clinical Trial in Australia focused on the treatment of up to 10 patients suffering from severe coronary artery disease and heart muscle damage.
But in the rats given angioblast injections, left ventricular function improved by 30% within 15 weeks of treatment, compared to control rats injected with saline.
Melbourne, Australia, Dec 23, 2010 - (ABN Newswire) - Regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced that it had completed its acquisition of United States company Angioblast Systems Inc with the issue of 90.
He was chairman of the Board of AtCor Medical and has served as Director on the Boards of Angioblast Systems and Sunshine Heart.
Mesoblast also advises that it has finalized the acquisition of its United States associate company, Angioblast Systems Inc.
127 ANGIOBLAST SYSTEMS 127 ARTERIOCYTE 128 ATHERSYS INC.
Companies Listed Aastrom Biosciences Adiposet Ltd (merged into Regenerys) Advanced BioHealing (acquired by Shire) Advanced Cell Technology (ACT) Advanced Tissue Sciences (ATS) Advantagene Allosource AlphaTec Spine Altrika (acquired by Regenerys) Amedica Amgen Amorcyte (acquired by NeoStem) Amorepacific Corporation Amsterdam Molecular Therapeutics (predecessor of UniQure) AnGes MG Angioblast Systems (acquired by Mesoblast) Anika Therapeutics AnorMED (acquired by Genzyme) Anterogen (subsidiary of Bukwang Pharm Co Ltd) Arcarios B.
We are finalizing a major strategic acquisition of our United States associate company, Angioblast Systems, that will enable Mesoblast shareholders to enjoy all the commercial benefits of the unique technology platform
Melbourne, Australia, Nov 19, 2010 - (ABN Newswire) - Australian regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today announced that the required period for any antitrust objection under the United States Hart-Scott-Rodino(HSR) anti-trust improvement Act 1976 in respect of its acquisition of Angioblast Systems Inc.